IGC Pharma Ratios (2010-2026) | IGC

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)	33.77%	67.86%	43.66%	55.74%	66.98%	66.83%	30.72%	37.95%	45.95%	59.79%	65.20%	57.97%	59.93%	48.06%	40.47%	46.67%	46.95%	51.83%
EBT Margin (Quarter)	-2,322.08%	-7,757.14%	-1,676.76%	-5,330.33%	-1,313.68%	-1,208.91%	-677.41%	-2,427.71%	-373.87%	-842.27%	-2,739.71%	-977.97%	-874.26%	-416.75%	-711.67%	-363.03%	-487.50%	-953.40%
EBIT Margin (Quarter)	-2,849.35%	-7,764.29%	-1,679.58%	4,732.79%	-1,321.70%	-1,231.68%	-686.14%	3,081.93%	-385.41%	-856.01%	-1,469.61%	1,660.34%	-880.88%	-427.18%	-730.74%	-428.18%	-580.79%	-1,517.80%
EBITDA Margin (Quarter)	-2,433.77%	-7,721.43%	-1,622.54%	-5,498.36%	-1,416.98%	-1,299.01%	-695.78%	-2,403.01%	-372.25%	-863.92%	-2,730.88%	-977.29%	-875.37%	-420.39%	-718.68%	-361.21%	-488.41%	-963.35%
Operating Margin (Quarter)	-2,849.35%	-7,764.29%	-1,679.58%	4,732.79%	-1,321.70%	-1,231.68%	-686.14%	3,081.93%	-385.41%	-856.01%	-1,469.61%	1,660.34%	-880.88%	-427.18%	-730.74%	-428.18%	-580.79%	-1,517.80%
Net Margin (Quarter)	-2,322.08%	-7,757.14%	-1,676.76%	-5,330.33%	-1,313.68%	-1,208.91%	-677.41%	-2,427.71%	-373.87%	-842.27%	-2,739.71%	-977.97%	-874.26%	-416.75%	-711.67%	-363.03%	-487.50%	-953.40%
FCF Margin (Quarter)	-2,524.68%	-4,167.86%	-1,724.65%	-795.90%	-1,095.75%	-634.65%	-671.69%	-916.87%	-268.11%	-568.04%	-811.27%	-183.39%	-658.09%	-248.79%	-522.96%	-226.67%	-431.40%	-1,109.42%
Efficiency
Inventory Average (Quarter)	1.74M	1.09M	0.48M	2.03M	2.02M	0.33M	0.10M	0.04M	1.33M	1.33M	0.97M	0.99M	0.05M	0.05M	0.74M	1.40M	0.70M	0.35M	0.36M	0.35M
Assets Average (Quarter)	35.16M	34.14M	32.56M	29.06M	25.50M	23.06M	21.01M	18.62M	16.43M	16.09M	13.88M	10.58M	10.25M	10.48M	9.72M	8.91M	8.35M	8.84M	9.73M	9.45M
Equity Average (Quarter)	32.27M	31.50M	30.37M	26.68M	22.97M	21.09M	19.23M	16.61M	14.06M	13.65M	11.58M	8.19M	7.60M	7.63M	6.82M	6.29M	6.20M	7.08M	7.76M	6.77M
Invested Capital (Quarter)	31.74M	31.26M	29.48M	23.89M	22.04M	20.14M	18.32M	14.91M	13.20M	14.10M	9.05M	7.32M	7.88M	7.38M	6.26M	6.33M	6.08M	8.09M	7.60M	6.15M
Asset Utilization Ratio (Quarter)	0.01	0.01	0.01	0.01	0.02	0.03	0.04	0.05	0.08	0.08	0.09	0.13	0.10	0.11	0.13	0.14	0.16	0.13
Leverage & Solvency
Interest Coverage Ratio (Quarter)
Debt to Equity (Quarter)	0.00	0.00	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.07	0.04
Debt Ratio (Quarter)	0.00	0.00	0.00	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.02	0.02	0.01	0.05	0.02
Equity Ratio (Quarter)	0.92	0.92	0.94	0.89	0.91	0.92	0.91	0.87	0.84	0.85	0.80	0.74	0.74	0.71	0.69	0.72	0.77	0.83	0.76	0.67
Times Interest Earned (Quarter)
Dividends & Payouts
FCF Payout Ratio (Quarter)
Valuation
Enterprise Value (Quarter)	-13.32M	-14.40M	-11.94M	-10.46M	-8.05M	-6.82M	-5.12M	-3.50M	-2.18M	-3.12M	-1.38M	-1.20M	-1.82M	-1.55M	-0.47M	-0.41M	-0.45M	-1.16M	-0.98M	-0.26M
Return Ratios
Return on Sales (Quarter)	-0.23%	-0.78%	-0.17%	-0.53%	-0.13%	-0.12%	-0.07%	-0.24%	-0.04%	-0.08%	-0.27%	-0.10%	-0.09%	-0.04%	-0.07%	-0.04%	-0.05%	-0.10%
Return on Capital Employed (Quarter)	-6.39%	-14.89%	-15.48%	-11.84%	-15.78%	-8.77%	-9.13%	-14.66%	-12.52%	-12.82%	-21.03%	-33.13%	-38.50%	-29.38%	-16.08%	-111.89%	-105.08%	-110.45%
Return on Invested Capital (Quarter)
Return on Assets (Quarter)	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%	0.00%
Return on Equity (Quarter)	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.02%	-0.02%	-0.02%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%

Research Tools

Developers

IGC Pharma Ratios (2010-2026) | IGC

Research Tools

Developers

IGC Pharma Ratios (2010-2026) | IGC

Create an account

Sign In

Reset Password